WallStSmart
TENX

Tenax Therapeutics Inc

NASDAQ: TENX · HEALTHCARE · BIOTECHNOLOGY

$13.11
+2.58% today

Updated 2026-04-30

Market cap
$376.32M
P/E ratio
P/S ratio
414.72x
EPS (TTM)
$-1.34
Dividend yield
52W range
$5 – $18
Volume
0.5M

Tenax Therapeutics Inc (TENX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-2.15M$-1.14M$-2.28M$-4.06M$-8.59M$-8.40M$-4.92M$-9.26M$-9.26M$-9.75M$-15.87M$-12.14M$-5.50M$-7.56M$-9.27M$-10.86M$-12.01M$-5.90M$-14.81M$-35.80M
Capital expenditures$21787.00$83947.00$102101.00$99691.00$541722.00$463939.00$152051.00$147038.00$147038.00$109657.00$2884.00$4537.00$7595.00$3573.00$3490.00$5252.00$2327.00$2843.00$0.00$0.00
Depreciation$263253.00$152122.00$102455.00$20475.00$110631.00$311026.00$148804.00$150489.00$150489.00$148140.00$18952.00$13621.00$9016.00$107279.00$114748.00$108982.00$113332.00$8000.00$0.00
Stock-based comp$12460.00$12460.00$336750.00$336750.00$192.00$8694.00$117295.00$975.00$1062.00$79589.00$190083.00$271.00$352.00$773.00$365.00$191000.00$1.13M$19.16M
Free cash flow$-2.17M$-1.22M$-2.38M$-4.16M$-9.13M$-8.87M$-5.07M$-9.41M$-9.41M$-9.86M$-15.87M$-12.15M$-5.51M$-7.56M$-9.28M$-10.86M$-12.02M$-5.91M$-14.81M$-35.80M
Investing cash flow$-56178.00$-19283.00$-102101.00$-367327.00$-541722.00$-463939.00$-147987.00$-147038.00$-40.93M$-40.93M$22.21M$3.75M$7.35M$-1651.00$20109.00$452609.00$-2323.00$3000.00
Financing cash flow$1.62M$1.17M$7.24M$2.10M$7.21M$9.19M$3.97M$66.95M$66.95M$280590.00$280590.00$498491.00$8.91M$96500.00$10.60M$9.74M$8.55M$13.57M$99.87M
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$7.33M
Share repurchases
Debt repayment
Net change in cash$927928.00$-1.10M$57.54M$-50.39M$6.34M$-8.39M$10.76M$-7.46M$1.34M